Federal Circuit Upholds IPR Decision of Unpatentability in Skky v. MindGeek
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Written by Scott R. Seeley and Andrea Cheek
The Federal Circuit upheld an IPR final written decision by the PTAB holding that MindGeek’s claims were unpatentable in Skky, Inc. v. MindGeek, S.A.R.L., No. 2016-2018 (Fed. Cir. June 7, 2017).
MindGeek filed a petition for inter partes review of Skky’s patent. The challenged claims were directed to a method of transmitting multimedia files to a “wireless device means.” The Board found that “wireless device means” does not invoke § 112 ¶ 6, because the phrase is not associated with a function. Under this construction, the Board found the challenged claims invalid as obvious in view of two references. Skky appealed. The Federal Circuit affirmed the Board’s finding.
The Federal Circuit noted that it is not bound by the Examiner’s understanding during prosecution that the claim term invoked § 112 ¶ 6. Moreover, the Federal Circuit stated that determining whether a claim term invokes § 112 ¶ 6 does not turn on the mere presence of the word “means.” Instead, the determination turns on whether the claim term is understood by the skilled artisan to designate structure. Here, the term “wireless device,” is used in common parlance to designate structure. Despite use of the term “means,” the phrase lacked any associated function. Thus, the presumption that the phrase was a means-plus-function limitation was overcome. Under this construction, the Federal Circuit upheld the Board’s determination of obviousness.
More insights
Fresh From the Bench: Latest Precedential Patent Case
Ridge Corp. et al. v. Kirk NationaLease Co. et al. , Appeal No. 2025-1254 (Fed. Cir. July 13, 2026) In its only precedential patent opinion last week, the Federal Circuit considered an appeal of a preliminary injunction issued by the U.S. District Court…
Fresh From the Bench: Latest Precedential Patent Cases
CASE OF THE WEEK Wyeth LLC v. AstraZeneca Pharmaceuticals LP , Appeal No. 2024-2325 (Fed. Cir. July 9, 2026) In our Case of the Week, the Federal Circuit affirmed a district court ruling reversing a $107.5 million jury verdict against AstraZeneca in a case…
Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026)
CASE OF THE WEEK Enanta Pharmaceuticals, Inc. v. Pfizer Inc., Appeal No. 2025-1427 (Fed. Cir. Jun. 23, 2026) In our Case of the Week, the Federal Circuit affirmed summary judgment invalidating all claims of Enanta’s Patent No. 11,358,953 as…